Selected research
Industry Growth & Trends
Global Montelukast Sodium Granules Industry Growth and Trends Forecast to 2032
Market perspective
The global Montelukast Sodium Granules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Montelukast Sodium Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Montelukast Sodium Granules include Teva Pharmaceutical Industries, Organon LLC, Novartis, Hengrui Medicine, Hybio Pharmaceutical, Pfizer, Mylan Pharmaceuticals, Luye Pharma Group and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Montelukast Sodium Granules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Montelukast Sodium Granules market size, estimates, and forecasts are presented in terms of sales volume (K G) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Montelukast Sodium Granules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Montelukast Sodium Granules.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Montelukast Sodium Granules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Montelukast Sodium Granules Market by Company
Teva Pharmaceutical Industries
Organon LLC
Novartis
Hengrui Medicine
Hybio Pharmaceutical
Pfizer
Mylan Pharmaceuticals
Luye Pharma Group
Dr. Reddy's Laboratories
Dong-A ST
Montelukast Sodium Granules Segment by Type
5mg
10mg
Montelukast Sodium Granules Segment by Application
Hospital
Clinic
Others
Montelukast Sodium Granules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Granules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Montelukast Sodium Granules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Montelukast Sodium Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceutical Industries
- Organon LLC
- Novartis
- Hengrui Medicine
- Hybio Pharmaceutical
- Pfizer
- Mylan Pharmaceuticals
- Luye Pharma Group
- Dr. Reddy's Laboratories
- Dong-A ST
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Montelukast Sodium Granules Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Montelukast Sodium Granules Sales Estimates and Forecasts (2021-2032)
- 1.3 Montelukast Sodium Granules Market by Type
- 1.3.1 5mg
- 1.3.2 10mg
- 1.4 Global Montelukast Sodium Granules Market Size by Type
- 1.4.1 Global Montelukast Sodium Granules Market Size Overview by Type (2021-2032)
- 1.4.2 Global Montelukast Sodium Granules Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Montelukast Sodium Granules Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Montelukast Sodium Granules Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Montelukast Sodium Granules Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Montelukast Sodium Granules Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Montelukast Sodium Granules Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Montelukast Sodium Granules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Montelukast Sodium Granules Industry Trends
- 2.2 Montelukast Sodium Granules Industry Drivers
- 2.3 Montelukast Sodium Granules Industry Opportunities and Challenges
- 2.4 Montelukast Sodium Granules Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Montelukast Sodium Granules Revenue (2021-2026)
- 3.2 Global Top Players by Montelukast Sodium Granules Sales (2021-2026)
- 3.3 Global Top Players by Montelukast Sodium Granules Price (2021-2026)
- 3.4 Global Montelukast Sodium Granules Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Montelukast Sodium Granules Major Company Production Sites & Headquarters
- 3.6 Global Montelukast Sodium Granules Company, Product Type & Application
- 3.7 Global Montelukast Sodium Granules Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Montelukast Sodium Granules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Montelukast Sodium Granules Players Market Share by Revenue in 2025
- 3.8.3 2025 Montelukast Sodium Granules Tier 1, Tier 2, and Tier 3
4 Montelukast Sodium Granules Regional Status and Outlook
- 4.1 Global Montelukast Sodium Granules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Montelukast Sodium Granules Historic Market Size by Region
- 4.2.1 Global Montelukast Sodium Granules Sales in Volume by Region (2021-2026)
- 4.2.2 Global Montelukast Sodium Granules Sales in Value by Region (2021-2026)
- 4.2.3 Global Montelukast Sodium Granules Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Montelukast Sodium Granules Forecasted Market Size by Region
- 4.3.1 Global Montelukast Sodium Granules Sales in Volume by Region (2027-2032)
- 4.3.2 Global Montelukast Sodium Granules Sales in Value by Region (2027-2032)
- 4.3.3 Global Montelukast Sodium Granules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Montelukast Sodium Granules by Application
- 5.1 Montelukast Sodium Granules Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Montelukast Sodium Granules Market Size by Application
- 5.2.1 Global Montelukast Sodium Granules Market Size Overview by Application (2021-2032)
- 5.2.2 Global Montelukast Sodium Granules Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Montelukast Sodium Granules Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Montelukast Sodium Granules Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Montelukast Sodium Granules Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Montelukast Sodium Granules Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Montelukast Sodium Granules Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Montelukast Sodium Granules Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceutical Industries
- 6.1.1 Teva Pharmaceutical Industries Company Information
- 6.1.2 Teva Pharmaceutical Industries Business Overview
- 6.1.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio
- 6.1.5 Teva Pharmaceutical Industries Recent Developments
- 6.2 Organon LLC
- 6.2.1 Organon LLC Company Information
- 6.2.2 Organon LLC Business Overview
- 6.2.3 Organon LLC Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Organon LLC Montelukast Sodium Granules Product Portfolio
- 6.2.5 Organon LLC Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Montelukast Sodium Granules Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Hengrui Medicine
- 6.4.1 Hengrui Medicine Company Information
- 6.4.2 Hengrui Medicine Business Overview
- 6.4.3 Hengrui Medicine Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hengrui Medicine Montelukast Sodium Granules Product Portfolio
- 6.4.5 Hengrui Medicine Recent Developments
- 6.5 Hybio Pharmaceutical
- 6.5.1 Hybio Pharmaceutical Company Information
- 6.5.2 Hybio Pharmaceutical Business Overview
- 6.5.3 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio
- 6.5.5 Hybio Pharmaceutical Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Montelukast Sodium Granules Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 Mylan Pharmaceuticals
- 6.7.1 Mylan Pharmaceuticals Company Information
- 6.7.2 Mylan Pharmaceuticals Business Overview
- 6.7.3 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio
- 6.7.5 Mylan Pharmaceuticals Recent Developments
- 6.8 Luye Pharma Group
- 6.8.1 Luye Pharma Group Company Information
- 6.8.2 Luye Pharma Group Business Overview
- 6.8.3 Luye Pharma Group Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Luye Pharma Group Montelukast Sodium Granules Product Portfolio
- 6.8.5 Luye Pharma Group Recent Developments
- 6.9 Dr. Reddy's Laboratories
- 6.9.1 Dr. Reddy's Laboratories Company Information
- 6.9.2 Dr. Reddy's Laboratories Business Overview
- 6.9.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio
- 6.9.5 Dr. Reddy's Laboratories Recent Developments
- 6.10 Dong-A ST
- 6.10.1 Dong-A ST Company Information
- 6.10.2 Dong-A ST Business Overview
- 6.10.3 Dong-A ST Montelukast Sodium Granules Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Dong-A ST Montelukast Sodium Granules Product Portfolio
- 6.10.5 Dong-A ST Recent Developments
7 North America by Country
- 7.1 North America Montelukast Sodium Granules Sales by Country
- 7.1.1 North America Montelukast Sodium Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Montelukast Sodium Granules Sales by Country (2021-2026)
- 7.1.3 North America Montelukast Sodium Granules Sales Forecast by Country (2027-2032)
- 7.2 North America Montelukast Sodium Granules Market Size by Country
- 7.2.1 North America Montelukast Sodium Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Montelukast Sodium Granules Market Size by Country (2021-2026)
- 7.2.3 North America Montelukast Sodium Granules Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Montelukast Sodium Granules Sales by Country
- 8.1.1 Europe Montelukast Sodium Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Montelukast Sodium Granules Sales by Country (2021-2026)
- 8.1.3 Europe Montelukast Sodium Granules Sales Forecast by Country (2027-2032)
- 8.2 Europe Montelukast Sodium Granules Market Size by Country
- 8.2.1 Europe Montelukast Sodium Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Montelukast Sodium Granules Market Size by Country (2021-2026)
- 8.2.3 Europe Montelukast Sodium Granules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Montelukast Sodium Granules Sales by Country
- 9.1.1 Asia-Pacific Montelukast Sodium Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Montelukast Sodium Granules Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Montelukast Sodium Granules Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Montelukast Sodium Granules Market Size by Country
- 9.2.1 Asia-Pacific Montelukast Sodium Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Montelukast Sodium Granules Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Montelukast Sodium Granules Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Montelukast Sodium Granules Sales by Country
- 10.1.1 South America Montelukast Sodium Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Montelukast Sodium Granules Sales by Country (2021-2026)
- 10.1.3 South America Montelukast Sodium Granules Sales Forecast by Country (2027-2032)
- 10.2 South America Montelukast Sodium Granules Market Size by Country
- 10.2.1 South America Montelukast Sodium Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Montelukast Sodium Granules Market Size by Country (2021-2026)
- 10.2.3 South America Montelukast Sodium Granules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Montelukast Sodium Granules Sales by Country
- 11.1.1 Middle East and Africa Montelukast Sodium Granules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Montelukast Sodium Granules Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Montelukast Sodium Granules Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Montelukast Sodium Granules Market Size by Country
- 11.2.1 Middle East and Africa Montelukast Sodium Granules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Montelukast Sodium Granules Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Montelukast Sodium Granules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Montelukast Sodium Granules Value Chain Analysis
- 12.1.1 Montelukast Sodium Granules Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Montelukast Sodium Granules Production Mode & Process
- 12.2 Montelukast Sodium Granules Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Montelukast Sodium Granules Distributors
- 12.2.3 Montelukast Sodium Granules Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst